ArticleThe Lancet regional health. Western Pacific2025
Opportunities and challenges of conducting vaccine research in low and middle-income countries in the Asia-Pacific region: perspectives from the Asia-Pacific Vaccine Research Network.
Article in The Lancet regional health. Western Pacific, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Global, regional, and national burden of encephalitis from 1990 to 2021: result from the global burden of disease study 2021.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
During the COVID-19 pandemic, vaccine technology and development advanced substantially in high-income countries, but this progress was not followed by the equitable knowledge transfer and accessibility and uptake of vaccines, particularly among low-and middle-income countries (LMICs). The Asia-Pacific Vaccine Research Network is a collaborative platform that aims to address common challenges faced by Asia-Pacific LMICs in undertaking vaccine research and barriers to evidence-based immunisation policy and practice. A network workshop was held in 2023 that aimed to identify critical challenges and opportunities to advance vaccine research to inform immunisation policy in LMICs in the Asia-Pacific. We found common themes to be challenges and opportunities in vaccine research capacity and infrastructure, workforce availability, financing and regulatory issues. To help to address some of these common challenges across the region, the Asia-Pacific Vaccine Research Network aims to facilitate the upskilling of vaccine research capability and knowledge exchange by bringing together experts and stakeholders from diverse backgrounds and through collaboration.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.